» Articles » PMID: 8981943

Most Germ-line Mutations in the Nevoid Basal Cell Carcinoma Syndrome Lead to a Premature Termination of the PATCHED Protein, and No Genotype-phenotype Correlations Are Evident

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 1997 Jan 1
PMID 8981943
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The human homologue of the Drosophila segment polarity gene patched is implicated in the development of nevoid basal cell carcinoma syndrome (NBCCS) and in the genesis of sporadic basal cell carcinomas. In order to examine the phenotypic variability in NBCCS and to highlight functionally important domains of the PTCH protein, we have now screened 71 unrelated NBCCS individuals for mutations in the PTCH exons. We identified 28 mutations that are distributed throughout the entire gene, and most (86%) cause protein truncation. As part of this analysis, we demonstrate that failure of one NBCCS family to show clear linkage to chromosome 9q22.3-31 is most likely due to germinal mosaicism. We have identified three families bearing identical mutations with variable phenotypes, suggesting phenotypic variability in NBCCS is a complex genetic event. No phenotype genotype correlation between the position of truncation mutations and major clinical features was evident. Two missense mutations have been identified, and their location within transmembrane domains supports the notion that PTCH may have a transport function. The preponderance of truncation mutants in the germ line of NBCCS patients suggests that the developmental defects associated with the disorder are most likely due to haploinsufficiency.

Citing Articles

Case report: A novel PTCH1 frameshift mutation leading to nevoid basal cell carcinoma syndrome.

Lang X, Wang T, Guo S, Dang Y, Zhang Y, Liu H Front Med (Lausanne). 2024; 11:1327505.

PMID: 38500952 PMC: 10946671. DOI: 10.3389/fmed.2024.1327505.


The energetics and ion coupling of cholesterol transport through Patched1.

Ansell T, Corey R, Viti L, Kinnebrew M, Rohatgi R, Siebold C Sci Adv. 2023; 9(34):eadh1609.

PMID: 37611095 PMC: 10446486. DOI: 10.1126/sciadv.adh1609.


Establishment of induced pluripotent stem cells derived from patients and healthy siblings of a nevoid basal cell carcinoma syndrome family.

Nakase Y, Hamada A, Obayashi F, Kitamura N, Hata T, Yamamoto T In Vitro Cell Dev Biol Anim. 2023; 59(6):395-400.

PMID: 37460876 PMC: 10374668. DOI: 10.1007/s11626-023-00778-y.


The Energetics and Ion Coupling of Cholesterol Transport Through Patched1.

Ansell T, Corey R, Viti L, Kinnebrew M, Rohatgi R, Siebold C bioRxiv. 2023; .

PMID: 36824746 PMC: 9949057. DOI: 10.1101/2023.02.14.528445.


Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.

Ewing A, Cheetham S, McGill J, Sharkey M, Walker R, West J Am J Med Genet A. 2021; 185(7):2070-2083.

PMID: 33960642 PMC: 8251932. DOI: 10.1002/ajmg.a.62224.


References
1.
GORLIN R . Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore). 1987; 66(2):98-113. DOI: 10.1097/00005792-198703000-00002. View

2.
Vortkamp A, Gessler M, Grzeschik K . GLI3 zinc-finger gene interrupted by translocations in Greig syndrome families. Nature. 1991; 352(6335):539-40. DOI: 10.1038/352539a0. View

3.
Ingham P, Taylor A, Nakano Y . Role of the Drosophila patched gene in positional signalling. Nature. 1991; 353(6340):184-7. DOI: 10.1038/353184a0. View

4.
Chenevix-Trench G, Leary J, Kerr J, Michel J, Kefford R, Hurst T . Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene. 1992; 7(6):1059-65. View

5.
Evans D, Ladusans E, Rimmer S, Burnell L, Thakker N, Farndon P . Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet. 1993; 30(6):460-4. PMC: 1016416. DOI: 10.1136/jmg.30.6.460. View